Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Physiotherapy and Dysfunctional Breathing (HVS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2009 by Royal Brompton & Harefield NHS Foundation Trust.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Royal Brompton & Harefield NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT00895219
First received: May 7, 2009
Last updated: NA
Last verified: April 2009
History: No changes posted
  Purpose

Traditionally, the physiotherapy management of people with dysfunctional breathing or hyperventilation syndrome is breathing re-training. There is increasing clinical evidence that structural and functional changes develop in the muscles and connective tissues of the chest wall, abdomen and back when the upper chest accessory pattern of breathing is used over time. When treatment includes breathing techniques only it is difficult for a person with chronic hyperventilation, who has developed muscle and connective tissue changes, to revert to using the normal lower chest diaphragmatic breathing pattern. In clinical practice when the problems which have developed in the musculoskeletal system are addressed, the patient reverts more quickly to the lower chest pattern of breathing but there is as yet little evidence to support this clinical finding.


Condition Intervention Phase
Hyperventilation
Other: Breathing re-training
Other: Breathing re-training and musculoskeletal techniques
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Comparison of the Effects of Respiratory Physiotherapy Alone and Respiratory Physiotherapy Combined With Musculoskeletal Techniques in the Management of Dysfunctional Breathing

Further study details as provided by Royal Brompton & Harefield NHS Foundation Trust:

Primary Outcome Measures:
  • Nijmegen Questionnaire [ Time Frame: 0, 2, 4, 8, 12 and 26 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Six-minute walking test [ Time Frame: 0, 2, 4, 8, 12 & 26 weeks ] [ Designated as safety issue: No ]

Enrollment: 60
Study Start Date: July 2007
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
Breathing re-training
Other: Breathing re-training
Breathing re-training
Active Comparator: 2
Breathing re-training and musculoskeletal physiotherapy techniques
Other: Breathing re-training and musculoskeletal techniques
Breathing re-training and musculoskeletal physiotherapy techniques including mobilisation techniques to normalise muscle and joint restrictions, doming of the diaphragm to enhance contraction and relaxation, and rib raising to free restriction in rib cage motion.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • diagnosis of dysfunctional breathing (Nijmegen score of more than 23)

Exclusion Criteria:

  • active metastatic disease
  • osteoporotic disease
  • dysfunctional breathing as a consequence of respiratory or cardiac disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00895219

Locations
United Kingdom
Royal Brompton Hospital
London, United Kingdom, SW3 6NP
Sponsors and Collaborators
Royal Brompton & Harefield NHS Foundation Trust
Investigators
Study Director: Margaret E Hodson, MD Royal Brompton & Harefield NHS Foundation Trust
  More Information

No publications provided

Responsible Party: Dr Jennifer A Pryor, Royal Brompton & Harefield NHS Trust
ClinicalTrials.gov Identifier: NCT00895219     History of Changes
Other Study ID Numbers: 06/Q0404/64
Study First Received: May 7, 2009
Last Updated: May 7, 2009
Health Authority: United Kingdom: National Health Service

Keywords provided by Royal Brompton & Harefield NHS Foundation Trust:
Hyperventilation
Dysfunctional breathing
Physiotherapy
Musculoskeletal techniques

Additional relevant MeSH terms:
Hyperventilation
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms
Signs and Symptoms, Respiratory

ClinicalTrials.gov processed this record on November 20, 2014